Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults

Elizabeth Winter*, Olaf Dekkers, Caroline Andreasen, Salvatore D'Angelo, Natasha Appelman-Dijkstra, Simone Appenzeller, Gunter Assmann, Judith Bubbear, Oana Bulaicon, Roland Chapurlat, Varvara Choida, Gavin P.R. Clunie, Dimitrios Daoussis, Torsten Diekhoff, Marcel Flendrie, Olivier Fogel, Roba Ghossan, Hermann Girschick, Femke van Haalen, Neveen HamdyBarbara Hauser, Christian Hedrich, Philip Helliwell, Kay Geert Hermann, Antonella Insalaco, Anne Grethe Jurik, Mitsumasa Kishimoto, Willem Lems, Paivi Miettunen, Burkhard Muche, Ana Navas Cañete, Natalia Palmou-Fontana, Frits Smit, James Teh, Charlotte Verroken, Kurt de Vlam, Daniel Wendling, Wei Zhou, Hans Georg Zmierczak, Anne Leerling

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

6 Citations (Scopus)

Abstract

Background: There is considerable practice variation in labelling, diagnosis and treatment of adults with sterile bone inflammation. We developed a expert consensus recommendations on the disease definition, diagnosis and treatment of this rare condition. Methods: Systematic literature review and Grading of Recommendations, Assessment, Development and Evaluations-based appraisal of evidence, two Delphi surveys and three digital and in-person consensus meetings with a multidisciplinary expert panel and patient representatives. Results: A consensus disease definition was developed and the term ’chronic non-bacterial osteitis’ (CNO) is proposed to describe adults with sterile bone inflammation. For initial imaging evaluation of adults with suspected CNO, the panel recommends MRI or otherwise CT combined with nuclear imaging. Whole-body imaging at initial evaluation can be considered for diagnostic and prognostic purposes. Suggested first-line treatment in adults with active CNO includes nonsteroidal anti-inflammatory drugs/cyclooxygenase 2-inhibitors. Second-line treatment preferably consists of intravenous bisphosphonates, and otherwise tumour necrosis factor-α inhibitors. Choice between them should be individualised, considering the presence of additional inflammatory features. The panel further discusses outcome measures, follow-up and management of adverse events and complications. Conclusions and future perspectives: These expert consensus recommendations are intended to support healthcare professionals worldwide in their care for adults with CNO. They also lay the groundwork for establishing international patient registries, translational research lines and multicentre trials, all of which are urgently required.

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume84
Issue2
Pages (from-to)169-187
Number of pages19
ISSN0003-4967
DOIs
Publication statusPublished - Feb 2025

Keywords

  • epidemiology
  • health care
  • magnetic resonance imaging
  • outcome and process assessment
  • tumor necrosis factors

Fingerprint

Dive into the research topics of 'Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults'. Together they form a unique fingerprint.

Cite this